Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70  Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns

CONCLUSION: A trend de-escalation of axillary staging was identified in this study, however the majority of patients meeting the 'Choosing Wisely' criteria are still undergoing SLNBx. No increased risk of nodal positivity was identified among patients with ILC, suggesting that surgeons can continue to choose wisely and limit the use of SLNBx in women over 70 years of age with T1 ILC tumors.PMID:37490163 | DOI:10.1245/s10434-023-13886-6
Source: Ann Oncol - Category: Cancer & Oncology Authors: Source Type: research